Francesca Allosso

Dr. Francesca Allosso

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2025 in European Journal of Endocrinology
Verified
Journal Article
Open access
KDKonstantinos Dalakas
Konstantinos Dalakas
FAFrancesca Allosso
Francesca Allosso
CBChristian Basile
Christian Basile
RBRagnhildur Bergthorsdottir
Ragnhildur Bergthorsdottir
DCDimitrios Chantzichristos
Dimitrios Chantzichristos
DEDaniela Esposito
Daniela Esposito
Objective: Despite important advances in the management of primary adrenal insufficiency (PAI), prognosis in these patients remains poor. Data on mortality in PAI has not been entirely consistent, and to date, no systematic synthesis has been performed. The aim of this study was to conduct a systematic review and a meta-analysis to synthesize available evidence on mortality in adult patients with PAI including congenital adrenal hyperplasia (CAH). Design: This is a systematic review and meta-analysis. Methods: Medline, Cochrane CENTRAL, Web of Science, and Embase databases were searched for studies on mortality in PAI. The results were screened by 2 reviewers by titles and abstracts, and selected articles were subsequently reviewed in full text. Observational studies on mortality compared to a reference population were included. Results: Out of the 6238 reports identified, 9 reports were included in the systematic review, with a total population of 13 969 patients. Two of the 9 studies included overlapping population; therefore, only 7 studies were included in the meta-analysis (9876 patients). Four studies assessed mortality utilizing hazard ratio (HR) with a pooled HR of 2.51 (95% confidence interval [CI] 1.47-4.31, I2 = 86.1%); 3 studies used standardized mortality ratio (SMR) with a pooled SMR of 2.49 (95% CI 0.99-6.28, I2 = 97.9%). The main cause of death was cardiovascular disease. A sub-analysis of patients with CAH showed a pooled HR of 2.88 (95% CI 1.38-6.01, I2 = 90.3%), with the main cause of death being adrenal crisis. Conclusions: Mortality in patients with PAI was increased 2.5-fold compared to the reference population.

29 August 2025 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
AMAldo Marrone
Aldo Marrone
FAFrancesca Allosso
Francesca Allosso
Alfredo CaturanoAlfredo Caturano
Alfredo Caturano
LSLucia Digitale Selvaggio
Lucia Digitale Selvaggio
MEMartina Errico
Martina Errico
DPDaniela Pasquali
Daniela Pasquali
Context: Klinefelter syndrome (KS) has a higher propensity for metabolic disorders and increased cardiovascular risk. The prevalence and the characteristics of metabolic dysfunction-associated steatotic liver disease (MASLD) have not been described yet in KS. Objective: We aim to study the relationship between hypogonadism, liver diseases, and cardiovascular risk using a unique KS model. Methods: This cross-sectional study included 82 patients with KS. Data collected included anthropometric measurements, hormonal and liver function parameters, and abdominal ultrasound findings. In a subgroup of 46 patients, hepatic steatosis was evaluated using the control attenuation parameter (CAP) via FibroScan. Cardiovascular risk was assessed using Score2 and Score2-Diabetes. Results: The prevalence of MASLD in patients with KS was 45.1%. Patients with MASLD were significantly older (P < .001), had higher body mass index (P < .001), waist circumference (P < .001), and a greater prevalence of diabetes (P = .004). In multivariable logistic regression analysis, metabolic syndrome was the only independent predictor of MASLD. For FibroScan/CAP evaluation, the median liver stiffness (KPa) was 4.7. The median CAP value was 244.0 ± 59.4 dB/m. Correlation analysis revealed a significant negative relationship between CAP and IGF-1 (P ≤ .001). In contrast, CAP was positively correlated with triglycerides (P = .020), insulin resistance index (P = .017), waist circumference (P < .001), and body mass index (P ≤ .001). Cardiovascular risk showed no significant differences between the MASLD and non-MASLD groups. Conclusion: This first study highlights substantial MASLD prevalence in patients with KS (45.1%). Metabolic syndrome is the major independent predictor of MASLD with a negative correlation between CAP and IGF-1. Early identification of MASLD is crucial to address the elevated risk of metabolic complications in this vulnerable population.

15 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MCMaddalena Casale
Maddalena Casale
MEMartina Errico
Martina Errico
RORaffaella Origa
Raffaella Origa
PMPaolo Mureddu
Paolo Mureddu
FAFrancesca Allosso
Francesca Allosso
Daniela PasqualiDaniela Pasquali
Daniela Pasquali
Background: Thyroid nodules are common in the general population, and up to 15% may be malignant. Patients with transfusion-dependent thalassemia (TDT) are predisposed to endocrine complications, raising concern for thyroid malignancy. This study compared surveillance strategies between TDT patients and healthy controls (HCs). Methods: This cross-sectional study used thyroid ultrasonography (US) to identify and characterize thyroid nodules in patients with TDT and HCs. Nodule assessment was performed using the Thyroid Imaging Reporting and Data System and the Italian Consensus for the Classification and Reporting of Thyroid Cytology for FNAs. Rates of indicated but unperformed FNAs and confirmed thyroid cancer cases were recorded. Statistical comparisons were performed using Fisher’s exact and chi-squared tests. Results: A total of 156 TDT and 101 HCs underwent thyroid US. Nodules were detected in 35.2% of TDT patients and 34.6% of HCs, with no difference in prevalence. Nodules were smaller in TDT patients, but suspicious ultrasound features and cancer prevalence were similar. Furthermore, 33.3% of TDT patients vs. 4.5% of HCs did not undergo indicated FNA (p = 0.021). Conclusions: Thyroid nodule prevalence and malignancy risk were comparable in TDT patients and HCs. A higher proportion of TDT patients missed indicated FNA procedures, revealing a critical gap in surveillance. Enhanced adherence to guideline-based follow-up is needed in thalassemia care.

8 October 2026 in Andrology
Verified
Journal Article
Open access
PDF file
FAFrancesca Allosso
Francesca Allosso
LSLucia Digitale Selvaggio
Lucia Digitale Selvaggio
Daniela PasqualiDaniela Pasquali
Daniela Pasquali
Background: Klinefelter syndrome (KS), typically characterized by a 47, XXY karyotype, is the most common sex chromosomal aneuploidy in males, with a prevalence of approximately one in 600–660 individuals. Despite its frequency, the syndrome remains significantly underdiagnosed, with 50%–75% of affected individuals never receiving a clinical diagnosis. While the classic phenotype includes hypergonadotropic hypogonadism and infertility, recent evidence highlights a lifelong burden of neurocognitive, psychological, and socioeconomic challenges. Objectives: This study synthesizes current evidence regarding the determinants of quality of life (QoL) in men with KS, specifically contextualizing the registry data and clinical trajectories discussed during the fourth International Workshop on Klinefelter Syndrome. Materials and Methods: To perform a narrative review, a literature search was conducted across major electronic databases, including PubMed/MEDLINE, Scopus, and the Cochrane Library. The search focused on peer‐reviewed articles published up to March 2026, utilizing primary keywords such as “Klinefelter Syndrome,” “47, XXY, ” “Quality of Life, ” “Socioeconomic Status, ” and “Testosterone Replacement Therapy.” Results: Affected individuals consistently report lower QoL across physical, psychological, and social domains compared to healthy controls, with social relationship scores often reaching levels observed in psychiatric reference populations. Key drivers of reduced well‐being include lower educational achievement, precarious employment, chronic health comorbidities, and experienced discrimination. Discussion: While testosterone replacement therapy is essential for physical virilization, it is frequently insufficient to normalize QoL or alleviate deep‐seated psychological distress, highlighting the impact of unmitigated developmental hurdles, metabolic burdens, and infertility‐related psychological trauma. Conclusion: A multidisciplinary approach—integrating endocrinology with specialized psychological, fertility, and educational support—is strictly required to address the complex, multidimensional needs of this population across the lifespan.

30 June 2026 in Indian Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
FMFederico Maria Mongardini
Federico Maria Mongardini
GBGiuseppe Bellastella
Giuseppe Bellastella
ACAlessandra Conzo
Alessandra Conzo
LFLuigi Flagiello
Luigi Flagiello
GMGloria Marchesiello
Gloria Marchesiello
GCGiovanni Conzo
Giovanni Conzo
Background: Long-term single center series remain useful for describing perioperative outcomes after laparoscopic adrenalectomy for Pheochromocytoma (PCC), particularly the clinical impact of intraoperative hemodynamic instability. Methods: We retrospectively reviewed all eligible consecutive patients who underwent laparoscopic adrenalectomy for histologically confirmed adrenal pheochromocytoma between January 2003 and December 2024. Patients with non-PCC adrenal disease, extra-adrenal paraganglioma, or lesions requiring upfront surgery for suspected invasion were excluded. Outcomes were analyzed descriptively. Results: Among 304 laparoscopic adrenalectomies, 64 patients (21.1%) had adrenal PCC. Mean age was 49.5 years (range, 20–79), 40 patients (62.5%) were female, and mean tumor size was 5.44 cm (range, 3.2–8.2). Conversion occurred in one patient (1.6%). Mean operative time was 100 min, mean blood loss was 120 mL, and no transfusions or 30-day deaths occurred. Thirty-day morbidity was 9.3%, with one Grade IIIa event and no Grade IV/V events. Hypertensive episodes, defined as systolic blood pressure > 180 mmHg, were recorded in 48 patients (75.0%) under continuous arterial monitoring. Hormonal normalization was achieved in 62 patients (96.8%) and blood pressure normalization in 58 (90.6%). During mean follow-up of 46.4 months (range, 4-150), one case of persistent disease and one local recurrence were observed; no distant metastasis or disease-specific death was observed. Conclusion: In selected adrenal PCCs, laparoscopic adrenalectomy was associated with low conversion, low morbidity, and high biochemical cure. The high rate of hypertensive episodes reflects the strict threshold used and does not support causal inference regarding morbidity.